Dr. Wharton is a cognitive neuroscientist specializing in Alzheimer’s disease (AD) and related disorders. She received her BA at the University of Texas at Austin and went on to complete her doctoral training at The George Washington University in Washington DC. She completed her postdoctoral fellowship at the University of Wisconsin in Madison. Her research focuses on the influence of vascular risk factors on Alzheimer’s biomarkers in individuals who are at risk for the disease due a parental history. She conducts both observational and clinical trials that investigate the extent to which blood pressure and blood pressure medications act on brain systems known to be involved in AD neuropathology. Dr. Wharton is currently conducting an NIH/NIA funded study investigating the influence of peripheral arterial function on AD biomarkers by measuring beta amyloid levels and blood flow in the brain in individuals at risk for AD. Her secondary area of research involves the influence of sex hormones and hormone therapy on cognition and AD neuropathology.